BP000470-PRO-318: Recombinant Human Coagulation Factor-VIII (FVIII) Protein
Source: CHO cells-derived.
The specific activity of recombinant human FVIII Protein was found to be 7428 IU/mg.
Purity: > 97.0% as determined by SDS-PAGE.BP000470-PRO-317: Human Coagulation Factor-VIII (FVIII) Protein
Source: Human Plasma-derived.
The potency per mg of Human Coagulation Factor-VIII was tested and found to be 150 Units/mg.BP001407-ENZ-589: Recombinant E.coli Formamidopyrimidine-DNA Glycosylase (Fpg) Enzyme
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP000993-PKA-245: Recombinant Human VEGFR3 Fc Chimera
Source: Insect Cells-derived.
Measured by its ability to bind recombinant rat VEGF-C in a functional solid phase binding assay. Immobilised recombinant human VEGFR-3/FLT-4 at 5 ?/ml can bind recombinant rat VEGF-C in a linear range of 8-500 ng/ml.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000993-PKA-244: Recombinant Human VEGFR3
Source: Insect Cells-derived.
Measured by its ability to bind recombinant rat VEGF-C in a functional solid phase binding assay. Immobilised recombinant human VEGFR-3/FLT-4 at 5 ng/ml can bind recombinant rat VEGF-C in a linear range of 8-500 ng/ml.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000045-CYT-157: Recombinant Rhesus Macaque Flt3 Ligand
Source: E. coli-derived.
The ED50 as calculated by the dose-dependant stimulation of the proliferation of human AML5 cells is less than 1.0 ng/ml, corresponding to a specific activity of 1,000,000 IU/mg.
Purity: > 97.0% as determined by SDS-PAGE.BP000045-CYT-331: Recombinant Human Flt3 Ligand
Source: E. coli-derived.
The ED50 range=0.5-1.0 ng/ml corresponding to a specific activity of 1-2 MUnits/mg, calculated by the dose-dependant stimulation of the proliferation of human OCMI-AML5 cells.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000992-PKA-240: Recombinant Human VEGFR1
Source: Insect Cells-derived.
The activity of FLT1 was determined by its ability to abolish the binding of iodinated VEGF to solid surfaces or cell surface receptors. The ED50 for this effect is typically 10 ng/ml, corresponding to a specific activity of 100,000IU/mg.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000992-PKA-354: Recombinant Human VEGFR1, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000988-PKA-234: Recombinant Human VEGFR1 D3
Source: Insect Cells-derived.
The activity of FLT1D1-3 was determined by its ability to abolish the binding of iodinated VEGF to solid surfaces or cell surfaces receptors, and in Far-Western and cross-linking experiments with iodinated VEGF.
Purity > 90%, by RP-HPLC and SDS-PAGE.